Functionally defined therapeutic targets in diffuse intrinsic pontine glioma

Grasso, Catherine S, Tang, Yujie, Truffaux, Nathalene, Berlow, Noah E, Liu, Lining, Debily, Marie-Anne, Quist, Michael J, Davis, Lara E +32 more·2015·Nature Medicine
DOI 10.1038/nm.3855

Cited by (686)

Items 501–600 of 686

  1. Approach to integrating molecular markers for assessment of pediatric gliomas
    Swati Mahajan, Mehar Chand Sharma, Chitra Sarkar, Vaishali S. Suri · 2021 · International Journal of Neurooncology
  2. Biological, Diagnostic, and Therapeutic Insights from (Epi)Genomic Profiling of Pediatric Brain Tumors
    Antonella De Cola, Amelia Foss, Richard J. Gilbertson, Manav Pathania · 2023 · Annual Review of Cancer Biology
  3. Tumor deconstruction as a tool for advanced drug screening and repositioning
    Rutika R. Naik, Ting Luo, Mohammad Kohandel, Sharmila A. Bapat · 2016 · Pharmacological Research
  4. L’art de la guerre appliqué aux DIPG
    Quentin Bailleul, Andria Rakotomalala, Isabelle Ferry, Pierre Leblond, Samuel Meignan, Alessandro Furlan · 2021 · médecine/sciences
  5. Diffuse Intrinsic Pontine Glioma
    Santosh Valvi, Nicholas G. Gottardo · 2018 · InTech eBooks
  6. Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma
    Evanthia Galanis, Patrick Yung Wen, John de Groot, Michael Weller · 2021 · Hematology/Oncology Clinics of North America
  7. JNO special issue: an update on pediatric neuro-oncology
    Lindsay Baker Kilburn, Roger J. Packer · 2020 · Journal of Neuro-Oncology
  8. Copy-number alterations reshape the classification of diffuse intrinsic pontine gliomas. First exome sequencing results of the BIOMEDE trial
    Thomas Kergrohen, David Castel, Gwénaël Le Teuff, Arnault Tauziède‐Espariat, Emmanuèle Lechapt, Karsten Nysom, Klas Blomgren, Pierre Leblond, Anne‐Isabelle Bertozzi, Émilie De Carli et al. · 2021 · medRxiv
  9. Cooperativity between H3.3K27M and PDGFRA poses multiple therapeutic vulnerabilities in human iPSC-derived diffuse midline glioma avatars
    Kasey Skinner, Tomoyuki Koga, Shunichiro Miki, Robert F. Gruener, Florina Grigore, Emma H. Torii, Davis M. Seelig, Yuta Suzuki, Daisuke Kawauchi, Benjamin Lin et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Progress Toward Epigenetic Targeted Therapies for Childhood Cancer
    Athanasia Liapodimitri, Ashley R Tetens, Jordyn Craig-Schwartz, Kayleigh Lunsford, Kegan O. Skalitzky, Michael A. Koldobskiy · 2024 · Cancers
  11. Case Report: Application of ex-vivo drug sensitivity testing to identify personalized treatment options for an adolescent with diffuse midline glioma
    Philip K. Tan, Timothy J. Martins, Pamela Sue Becker, Robert J. Wechsler‐Reya, John Ross Crawford · 2025 · Frontiers in Oncology
  12. Novel Diffuse Midline Glioma‐on‐Chip Recapitulating Tumor Biophysical Microenvironment to Assess the Heterogeneity of Response to Therapies
    Lisa Terrassoux, Calypso Hazard, Agathe Laratte, Joanne Balsamelli, Mélanie Arcicasa, Eliza Li Shan Fong, Léo Baland, Fabrice Soncin, Giovanni Cappello, Claude‐Alain Maurage et al. · 2025 · Small
  13. Pharmacological targeting and characterization of Voltage-Gated Sodium Channels (VGSCs) expressed in the high-grade glioma microenvironment
    Emily V. Fletcher, Chloé Shard, Yasmin Boyle, Carol J. Milligan, Ryan Stanley Cross, Anya C. Jones, Abbie Francis, Brittany Dewdney, Matt Barker, Sara Rezaeiravesh et al. · 2025 · BMC Cancer
  14. Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma
    Julian S. Rechberger, Wouter J. F. Vanbilloen, Leo F. Nonnenbroich, Jizhi Ge, Randy S. Schrecengost, Rachael A. Vaubel, Liang Zhang, David J. Daniels · 2026 · Communications Biology
  15. Metabolic dependencies and neural progenitor dysregulation: driving forces in paediatric high-grade glioma development
    Yan Hay Grace Lee, Maria Tsoli, Yan Chuan Shi, Chi Kin Ip, David Ziegler · 2026 · Cancer and Metastasis Reviews
  16. The combinations of histone lysine demethylase inhibitors with panobinostat exert enhanced effects against head and neck cancer cells
    Dawid Dorna, Robert Kleszcz, Karolina Drabarz, Małgorzata Kubiak, Barbara Stefañska, Jarosław Paluszczak · 2026 · Experimental Cell Research
  17. Microglia in diffuse midline glioma contribute to extracellular matrix remodelling and cancer cell invasion
    Lily Keane, Martin Škandík, Mercedes Posada-Pérez, Raj Bose, John Desito, Esmee van der Linde, Pinelopi Engskog‐Vlachos, Sandra Ceccatelli, Adam L. Green, Bertrand Joseph · 2026 · Cell Death and Disease
  18. Stereotactic Brainstem Biopsy: Technical Aspects with Emphasis on Role of Awake Craniotomy
    Reddy Kanala Ramnadh, Vamsi Krishna Yerramneni, Thirumal Yerragunta, Kumar Arvind, Varshesh K. Shah · 2020 · Indian Journal of Neurosurgery
  19. Histone H3 K27 alterations in central nervous system tumours: Challenges and alternative diagnostic approaches
    Nour Kurdi, Attila Mokánszki, Gábor Méhes, Judit Bedekovics · 2022 · Molecular and Cellular Probes
  20. High Level Immunoglobulin Gene Expression and Reduced Intra-tumoral Bacteria Associated With the Transition from Initial to Progressive Diffuse Intrinsic Pontine Glioma
    Etienne C. Gozlan, Taha I. Huda, Jessica U. Quach, Mallika Varkhedi, John E. Desantis, George Blanck · 2024 · Anticancer Research
  21. An E2 ubiquitin-conjugating enzyme links diubiquitinated H2B to H3K27M oncohistone function
    Alan L. Jiao, Erdem Sendinc, Barry M. Zee, Felice Wallner, Yang Shi · 2024 · Proceedings of the National Academy of Sciences
  22. Highlights from the Literature
    Jason T. Huse, Roger Abounader, Benjamin W. Purow, Monika E. Hegi, Riccardo Soffietti, Kenneth Aldape · 2016 · Neuro-Oncology
  23. Combination therapy design for maximizing sensitivity and minimizing toxicity
    Kevin Matlock, Noah Berlow, Charles Keller, Ranadip Pal · 2016 · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB)
  24. Brainstem Tumors
    Peter A. Chiarelli, Jason K. Chu, Mark D. Krieger · 2020 · Springer eBooks
  25. Pediatric Glioma
    Erin Sennett Murphy, Matthew M. Poppe, Rakesh Jalali · 2018 · Pediatric oncology
  26. Pharmacokinetics of Panobinostat: Interspecies Difference in Metabolic Stability
    Wenqiu Zhang, Ju‐Hee Oh, Wenjuan Zhang, Courtney C. Aldrich, Rachael W. Sirianni, William F. Elmquist · 2024 · Journal of Pharmacology and Experimental Therapeutics
  27. Effects of Tyr555 and Trp678 on the processivity of cellobiohydrolase A from Ruminiclostridium thermocellum: A simulation study
    Fei Han, Ye Liu, E Jingwen, Shanshan Guan, Weiwei Han, Yaming Shan, Song Wang, Hao Zhang · 2018 · Biopolymers
  28. The natural compound obtusaquinone targets pediatric high-grade gliomas through ROS-mediated ER stress
    Jian Teng, Ghazal Lashgari, Elie I. Tabet, Bakhos A. Tannous · 2020 · Neuro-Oncology Advances
  29. Stemming the growth of pediatric gliomas through histone modification
    Daniel W. Fults · 2020 · Neuro-Oncology
  30. Developing Small Molecule Inhibitors of ALK2: A Serine/Threonine Kinase Implicated in Diffuse Intrinsic Pontine Glioma
    Deeba Ensan · 2020 · TSpace (University of Toronto)
  31. Consistently processed RNA sequencing data from 50 sources enriched for pediatric data
    Holly C. Beale, Katrina Learned, Ellen Towle Kephart, A. Geoffrey Lyle, Anouk van den Bout, Molly M. McCabe, Kathryn Echandia-Monroe, Mansi J Khare, Elise Y. Huang, Sneha Jariwala et al. · 2025 · Scientific Data
  32. Targeting SAGA/ATAC complexes disrupts chromatin regulation and cholesterol metabolism in diffuse midline glioma
    Rosemary U. Richard, Caitlin L. Bagnetto, Rebecca L. Murdaugh, Brittany R Eberl, Alan L. Jiao, Adam Fiseha Kebede, Ena I. Campos-Hensley, Barry M. Zee, Margaret M. Harrington, Mariella G. Filbin et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Boosting CAR T cell functionality with oncolytic viruses for the treatment of pediatric diffuse midline gliomas
    Konstantinos Vazaios, Antonio Carlos Tallon-Cobos, Louisa P.J. van Oosterhout, Piotr Waranecki, Annelisa M. Cornel, Noël M M Dautzenberg, Marliek van Hoesel, Caitlyn Forbes, Stefan Nierkens, Vera Kemp et al. · 2026 · Molecular Therapy Oncology
  34. Radiation and Chemotherapy for Brainstem Tumors
    Katherine E. Warren · 2020 · Springer eBooks
  35. Clinicohistoradiological and surgical outcome in diffuse midline glioma
    Arvind Kumar Suman, Suchanda Bhattacharjee, Megha S. Uppin, Syed Tazeem Fathima · 2023 · Child s Nervous System
  36. Addressing barriers in diffuse intrinsic pontine glioma: the transformative role of lipid nanoparticulate drug delivery
    Zenab Presswala, Sheetal Porecha Acharya, Shreeraj Shah · 2024 · ADMET & DMPK
  37. Pediatric High Grade Glioma
    Craig Alexander Erker, Magimairajan Vanan, Vivek Mehta, David D. Eisenstat · 2024 · Springer eBooks
  38. Small-Molecule Drugs in Pediatric Neuro-Oncology
    Stéphanie Vairy, George Michaiel · 2025 · Current Oncology
  39. Deciphering the tumor microenvironment and role of immunotherapy in diffuse midline glioma: A scoping review
    Christian Kieran Ramsoomair, Felipe Sarmiento, Deryn Ramsoomair, Manav Daftari, Jiasen He, Benjamin Glazer, Michelle Monje, Danny Reinberg, Ashish H Shah · 2026 · Neuro-Oncology
  40. Diffuse Midline Gliomas: Clinical, Diagnostic, and Therapeutic Perspectives
    Sanyukta Bihari, Dia Yang, Devarshi Mukherji, Aya M. Haggiagi · 2026 · Biomedicines
  41. The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, restores blood–brain barrier integrity in a human stem cell‐based model of ischaemic stroke
    Anikó Szecskó, Koppány Párdi, Zuhao Cui, Gergő Porkoláb, Zsófia Hoyk, Csilla Kovács, Janet Folasade Adegbite, Virág Fodor, Nárcisz M. Cser, László Dér et al. · 2026 · British Journal of Pharmacology
  42. Therapy-associated lineage plasticity in DIPG following combined CDK4/6 inhibitor, temozolomide, and radiation
    Zilu Huang, Tongchao Jiang, Milagros Melanie Suarez Palacios, Tommy Ouyang, Aalaa Sanad Abdallah, Long Niu, Jinnan Chen, Xin Zhai, Emily Ciolak, Wenan Qiang et al. · 2026 · Cancer Letters
  43. Efficacy of Combined Epigenetic Therapies
    Noël J.‐M. Raynal · 2016 · Elsevier eBooks
  44. Relationships between Models of Genetic Regulatory Networks with Emphasis on Discrete State Stochastic Models
    Randip Pal · 2016 · Advances in medical technologies and clinical practice book series
  45. Diffuse Intrinsic Pontine Glioma: A Therapeutic Challenge
    Heloisa H. Moser, Eshini Panditharatna, Roger J. Packer, Javad Nazarian · 2016 · InTech eBooks
  46. High-Grade Glioma, Including Diffuse Intrinsic Pontine Glioma
    Matthias A. Karajannis, Matija Snuderl, Brian K. Yeh, Michael Francis Walsh, Rajan Jain, Nikhil A. Sahasrabudhe, Jeffrey H. Wisoff · 2018 · Springer eBooks
  47. PROGNOSTICATE THE DRUGS FOR MULTIPLE MYELOMA PATIENTS BY USING GENE EXPRESSION TECHNIQUE WITH POLYCLONAL AND MONOCLONAL SAMPLES
    R. J. Hemalatha, T.P. Abhinayaa Devi · 2018 · ICTACT Journal on Image and Video Processing
  48. Transcriptional and epigenetic regulatory mechanisms in glioblastoma stem cells
    Raul Bardini Bressan, Steven M. Pollard · 2020 · Elsevier eBooks
  49. Genomic Heterogeneity of Aggressive Pediatric and Adult Diffuse Astrocytomas
    Christopher R. Pierson, Diana Thomas · 2021 · Molecular pathology library
  50. Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience
    Jennifer K. Matsui, Pamela K. Allen, Haley Kopp Perlow, Jason Michael Johnson, Arnold C. Paulino, Mary Frances McAleer, Maryam Fouladi, David R. Grosshans, Amol Jitendra Ghia, Jing Li et al. · 2023 · Journal of Neuro-Oncology
  51. HG-37SECOND RE-IRRADIATION FOR DIPG PROGRESSION, RE-CONSIDERING “OLD STRATEGIES” WITH NEW APPROACHES
    Andrés Morales La Madrid, Vicente Santa‐María, Ofelia Cruz Martinez, Álvaro Lassaletta, Normand Laperrière, S. Villà, Éric Bouffet · 2016 · Neuro-Oncology
  52. Pediatric High Grade Glioma
    Chitra Sarkar, Suvendu Purkait, Pankaj Pathak, Prerana Jha · 2017 · Current cancer research
  53. The significance of histone H3 K27M mutation in brain tumors
    Akitake Mukasa · 2017 · Progress in Neuro-Oncology
  54. The unexpected role of histones in childhood brain cancer
    Liam Drew · 2018 · Nature
  55. The dark matter of diffuse intrinsic pontine gliomas: an update
    Jacques Grill, Marie-Anne Debily, Pascale Varlet, Alexandre Plessier, Ludivine Le Dret, Kévin Beccaria, Stéphanie Puget, David Castel · 2018 · Expert Opinion on Orphan Drugs
  56. Diffuse Intrinsic Pontine Glioma: Translation of Genomic Knowledge to Clinical Practice
    Tina Z hou, Sara A. Khan, Ron Firestein, Peter Downie, Jason E. Cain · 2019 · OBM Neurobiology
  57. Update in Pediatric Neuro-Oncology
    Khatua, Soumen, Pillay Smiley, Natasha · 2019 · MDPI eBooks
  58. Translating preclinical hopes into clinical reality for children with ependymoma
    Jacques Grill · 2015 · Neuro-Oncology
  59. 745 Oncolytic adenovirus expressing 4-1BBL demonstrates a significant increase of survival in Diffuse Midline Glioma models
    Virginia Laspidea, Sara Labiano, Iker Ausejo‐Mauleon, Daniel de la Nava, Marc García-Moure, Javier Marco-Sanz, Juan Fueyo-Margareto, Candelaria Gomez‐Manzano, Ana Patiño‐García, Marta Alonso · 2021 · Journal for ImmunoTherapy of Cancer
  60. Integrative Multi-Omics Analysis Identifies Nuclear Factor I as a Key Driver of Dysregulated Purine Metabolism in DIPG
    Ian Mersich, Sunny Congrove, Matthew J. Horchar, Román Cáceres, Ranjithmenon Muraleedharan, Janki M. Desai, Pankaj B. Desai, Larry Sallans, Julie A. Reisz, Abby Grier et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  61. Epigenetische Strategien in der Krebstherapie
    Elisabeth Heßmann, Steven A. Johnsen, Volker Ellenrieder · 2015 · Der Onkologe
  62. Precision medicine in glioblastoma therapy
    Louis Royer-Perron, Ahmed Idbaïh, Marc Sanson, Jean‐Yves Delattre, Khê Hoang‐Xuan, Agustí Alentorn · 2016 · Expert Review of Precision Medicine and Drug Development
  63. Predictive modeling based on functional and genomic characterizations
    Ranadip Pal · 2016 · Elsevier eBooks
  64. Epigenetic dysregulation in brain tumors and neurodevelopment
    Marco M. Hefti, Nadejda M. Tsankova · 2016 · Elsevier eBooks
  65. Combination therapeutics
    Ranadip Pal · 2016 · Elsevier eBooks
  66. Preclinical models of childhood cancer for the development of targeted therapies
    Raushan T. Kurmasheva, Peter J. Houghton · 2016 · Drug Discovery Today Disease Models
  67. Target Inhibition Maps Based on Responses to Kinase Inhibitors
    Noah Berlow, Ranadip Pal · 2017 · Methods in molecular biology
  68. Diffuse Intrinsic Pontine Glioma: A multi-facetted and global view
    Sophie E. M. Veldhuijzen van Zanten · 2017 · Data Archiving and Networked Services (DANS)
  69. Genetic Basis and Classification of Cerebral Neoplasms
    Vijay Ramaswamy, Carolina Nör · 2020 · Springer eBooks
  70. Cell-based models for studying paediatric high-grade gliomas
    Susanna C. Larsson · 2019 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  71. Pharmacologic inhibition of lysine specific demethylase-1 (LSD1) as a therapeutic and immune-sensitization strategy in diffuse intrinsic pontine glioma (DIPG)
    Cavan P. Bailey, Megan M. Romero, Oren Josh Becher, Michelle Monje, Dean Anthony Lee, Linghua Wang, Joya Chandra · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  72. Future Therapies for Malignant Brainstem Tumors
    Zhiping Zhou, Mark M. Souweidane · 2020 · Springer eBooks
  73. Exploiter les dépendances non-oncogéniques afin d’identifier de nouvelles cibles thérapeutiques dans les cancers pédiatriques
    Virginie Ménez, Marie-Anne Debily · 2020 · médecine/sciences
  74. Diffuse Midline Glioma (H3K27M mutant) in Adult: A Diagnostic Challenge
    Sonal Paul, Nitin Maheshvar Gadgil, Chetan Sudhakar Chaudhari · 2020 · Annals of Pathology and Laboratory Medicine
  75. Pediatric glioblastoma - unlike normal cells - are sensitive to the combination of vorinostat and olaparib and to its downstream effector - phosphorylated eIF2α
    Karin Eytan, Ziv Versano, Moshe Leitner, Shoshana Paglin, Amos Toren, Michal Yalon · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  76. Delphes: le trésor de Siphnos
    Lerco Elisa · 2014 · Publications Docs-en-stock.com
  77. Relationships between Models of Genetic Regulatory Networks with Emphasis on Discrete State Stochastic Models
    Randip Pal · 2019 · IGI Global eBooks
  78. Neuro-Ophthalmologic Manifestations of Systemic and Intracranial Disease
    Michael C. Brodsky · 2016 · Springer eBooks
  79. Epigenetische Strategien in der Krebstherapie
    Elisabeth Heßmann, Steven A. Johnsen, Volker Ellenrieder · 2017 · best practice onkologie
  80. Faculty Opinions recommendation of Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma.
    Jason T. Huse · 2017 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  81. Isolation and Characterization of Immune Cells from the Tumor Microenvironment of Genetically Engineered Pediatric High Grade Glioma Models Using the Sleeping Beauty Transposon System v1
    María Belén Garcia-Fabiani, Andrea Comba, Padma Kadiyala, Santiago Haase, Felipe Javier Núñez, David Altshuler, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2020
  82. Mimicking and surpassing the cancer xenograft model with dynamic, in vivo-like, drug concentrations on-chip
    Job Komen · 2022
  83. Exophytic cerebellopontine angle tumor showing mostly an embryonal appearance with H3‐3A K27M
    Tatsuro Maehara, Ayako Yamazaki, Yoshiko Nakano, Satoshi Nakata, Kohei Fukuoka, Shoichi Deguchi, Koichi Mitsuya, Nakamasa Hayashi, Takuma Oishi, Yuko Kakuda et al. · 2022 · Neuropathology
  84. Untersuchung der therapeutischen Wirkmechanismen von Kurkumin in diffus intrinsischen Ponsgliomen in Abhängigkeit vom Mutationsstatus im H3F3A-Histongen (H3.3K27M-Mutation)
    Johanna Zastrow · 2022
  85. Oncolytic adenovirus Delta-24- RGD engineered to express 4-1BBL or OX40L as therapeutic approach for diffuse intrinsic pontine gliomas
    Virginia Laspidea · 2022
  86. Data from Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003
    Cassie Kline, Payal Jain, Lindsay Baker Kilburn, Erin E. Bonner, Nalin M. Gupta, John Ross Crawford, Anu Banerjee, Roger J. Packer, Javier E. Villanueva-Meyer, Tracy L. Luks et al. · 2023
  87. Data from Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma
    Trang Thi Thu Nguyen, Enyuan Shang, Salveena Schiffgens, Consuelo Torrini, Chang Shu, Hasan Orhan Akman, Varun V. Prabhu, Joshua E. Allen, Mike‐Andrew Westhoff, Georg Karpel‐Massler et al. · 2023
  88. Data from Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma
    Trang Thi Thu Nguyen, Enyuan Shang, Salveena Schiffgens, Consuelo Torrini, Chang Shu, Hasan Orhan Akman, Varun V. Prabhu, Joshua E. Allen, Mike‐Andrew Westhoff, Georg Karpel‐Massler et al. · 2023
  89. Supplementary table 3 from Pharmaceutical Interference of the EWS-FLI1–driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma
    Daniel A.R. Heisey, Sheeba Jacob, Timothy L. Lochmann, Richard Kurupi, Maninderjit S. Ghotra, Marissa L. Calbert, Mayuri Shende, Yuki Kato Maves, Jennifer E. Koblinski, Mikhail G. Dozmorov et al. · 2023
  90. Data from Pharmaceutical Interference of the EWS-FLI1–driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma
    Daniel A.R. Heisey, Sheeba Jacob, Timothy L. Lochmann, Richard Kurupi, Maninderjit S. Ghotra, Marissa L. Calbert, Mayuri Shende, Yuki Kato Maves, Jennifer E. Koblinski, Mikhail G. Dozmorov et al. · 2023
  91. Data from Transcriptomic Analysis of Diffuse Intrinsic Pontine Glioma (DIPG) Identifies a Targetable ALDH-Positive Subset of Highly Tumorigenic Cancer Stem-like Cells
    Rachel Kathleen Surowiec, Sarah F. Ferris, April Ann Apfelbaum, Carlos E. Espinoza, Ranjit Kumar Mehta, Karamoja Monchamp, Veerin R. Sirihorachai, Karan Bedi, Mats E. Ljungman, Stefanie Galbán · 2023
  92. Data from Transcriptomic Analysis of Diffuse Intrinsic Pontine Glioma (DIPG) Identifies a Targetable ALDH-Positive Subset of Highly Tumorigenic Cancer Stem-like Cells
    Rachel Kathleen Surowiec, Sarah F. Ferris, April Ann Apfelbaum, Carlos E. Espinoza, Ranjit Kumar Mehta, Karamoja Monchamp, Veerin R. Sirihorachai, Karan Bedi, Mats E. Ljungman, Stefanie Galbán · 2023
  93. Pediatric Brain and Brainstem Tumors
    Nir Shimony, Cameron Brimley, George I. Jallo, Paul D. Klimo · 2023 · Springer eBooks
  94. Enhancing Delivery and Efficacy of Panobinostat for Diffuse Midline Glioma through Focused Ultrasound-Mediated Blood-Brain Barrier Opening
    Payton J. Martinez, Jane J. Song, Kang-Ho Song, Mark Andrew Borden, Genna Nault, Jenna Steiner, Natalie Julie Serkova, Micheal F. Wempe, Angela M. Pierce, Breauna Brunt et al. · 2023 · IEEE International Ultrasonics Symposium
  95. Additional file 1 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Yukitomo Ishi, Eugene Chekalin, Billy Zeng, Benjamin Scott Glicksberg, Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare
  96. Additional file 3 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Yukitomo Ishi, Eugene Chekalin, Billy Zeng, Benjamin Scott Glicksberg, Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare
  97. Additional file 8 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Yukitomo Ishi, Eugene Chekalin, Billy Zeng, Benjamin Scott Glicksberg, Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare
  98. Additional file 7 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Yukitomo Ishi, Eugene Chekalin, Billy Zeng, Benjamin Scott Glicksberg, Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare
  99. Additional file 2 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Yukitomo Ishi, Eugene Chekalin, Billy Zeng, Benjamin Scott Glicksberg, Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare
  100. Additional file 6 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
    Guisheng Zhao, Patrick A. Newbury, Yukitomo Ishi, Eugene Chekalin, Billy Zeng, Benjamin Scott Glicksberg, Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Figshare